The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy

Michael T. Montgomery, Spencer W. Redding, Charles F. LeMaistre

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Oral lesions in twenty-nine immunocompromised patients were evaluated for the incidence of herpes simplex virus (HSV) infections during either cancer chemotherapy or cancer chemotherapy plus bone marrow transplantation (BMT). Patients' HSV antibody titers were not determined, and positive diagnoses were based solely on the results of viral cultures. Fourteen patients (48%) were found to have herpetic infections, which is comparable with incidence rates of 50% to 90% in antibody-positive patients and 40% to 50% in mixed antibody populations reported in the medical literature. However, this finding is in conflict with the 10.7% to 15.1% incidence rate cited in the dental literature for patients undergoing cancer chemotherapy. This underestimation is believed to reflect insensitivity in the criteria used for diagnosis in these studies.

Original languageEnglish (US)
Pages (from-to)238-242
Number of pages5
JournalOral Surgery, Oral Medicine, Oral Pathology
Volume61
Issue number3
DOIs
StatePublished - 1986

Fingerprint

Herpetic Stomatitis
Virus Diseases
Simplexvirus
Drug Therapy
Incidence
Antibodies
Neoplasms
Immunocompromised Host
Viral Load
Bone Marrow Transplantation
Tooth
Infection
Population

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dentistry(all)

Cite this

The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy. / Montgomery, Michael T.; Redding, Spencer W.; LeMaistre, Charles F.

In: Oral Surgery, Oral Medicine, Oral Pathology, Vol. 61, No. 3, 1986, p. 238-242.

Research output: Contribution to journalArticle

Montgomery, Michael T. ; Redding, Spencer W. ; LeMaistre, Charles F. / The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy. In: Oral Surgery, Oral Medicine, Oral Pathology. 1986 ; Vol. 61, No. 3. pp. 238-242.
@article{40c2af8ad6d74fc281c23a233a20651a,
title = "The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy",
abstract = "Oral lesions in twenty-nine immunocompromised patients were evaluated for the incidence of herpes simplex virus (HSV) infections during either cancer chemotherapy or cancer chemotherapy plus bone marrow transplantation (BMT). Patients' HSV antibody titers were not determined, and positive diagnoses were based solely on the results of viral cultures. Fourteen patients (48{\%}) were found to have herpetic infections, which is comparable with incidence rates of 50{\%} to 90{\%} in antibody-positive patients and 40{\%} to 50{\%} in mixed antibody populations reported in the medical literature. However, this finding is in conflict with the 10.7{\%} to 15.1{\%} incidence rate cited in the dental literature for patients undergoing cancer chemotherapy. This underestimation is believed to reflect insensitivity in the criteria used for diagnosis in these studies.",
author = "Montgomery, {Michael T.} and Redding, {Spencer W.} and LeMaistre, {Charles F.}",
year = "1986",
doi = "10.1016/0030-4220(86)90368-3",
language = "English (US)",
volume = "61",
pages = "238--242",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy

AU - Montgomery, Michael T.

AU - Redding, Spencer W.

AU - LeMaistre, Charles F.

PY - 1986

Y1 - 1986

N2 - Oral lesions in twenty-nine immunocompromised patients were evaluated for the incidence of herpes simplex virus (HSV) infections during either cancer chemotherapy or cancer chemotherapy plus bone marrow transplantation (BMT). Patients' HSV antibody titers were not determined, and positive diagnoses were based solely on the results of viral cultures. Fourteen patients (48%) were found to have herpetic infections, which is comparable with incidence rates of 50% to 90% in antibody-positive patients and 40% to 50% in mixed antibody populations reported in the medical literature. However, this finding is in conflict with the 10.7% to 15.1% incidence rate cited in the dental literature for patients undergoing cancer chemotherapy. This underestimation is believed to reflect insensitivity in the criteria used for diagnosis in these studies.

AB - Oral lesions in twenty-nine immunocompromised patients were evaluated for the incidence of herpes simplex virus (HSV) infections during either cancer chemotherapy or cancer chemotherapy plus bone marrow transplantation (BMT). Patients' HSV antibody titers were not determined, and positive diagnoses were based solely on the results of viral cultures. Fourteen patients (48%) were found to have herpetic infections, which is comparable with incidence rates of 50% to 90% in antibody-positive patients and 40% to 50% in mixed antibody populations reported in the medical literature. However, this finding is in conflict with the 10.7% to 15.1% incidence rate cited in the dental literature for patients undergoing cancer chemotherapy. This underestimation is believed to reflect insensitivity in the criteria used for diagnosis in these studies.

UR - http://www.scopus.com/inward/record.url?scp=0022619916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022619916&partnerID=8YFLogxK

U2 - 10.1016/0030-4220(86)90368-3

DO - 10.1016/0030-4220(86)90368-3

M3 - Article

C2 - 3010211

AN - SCOPUS:0022619916

VL - 61

SP - 238

EP - 242

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 3

ER -